MMRV(H)NS vaccine(Glaxosmithkline)

N/A

Report date: 2026/04/13 20:02:18

Base Information

Drug NameMMRV(H)NS vaccine(Glaxosmithkline)

Drug Alias NameM(L)M(L)R(L)V(L)NS vaccine; MM(H)RVNS vaccine(Glaxosmithkline)MMR-varicella zoster virus new strain vaccine(Glaxosmithkline)MMRV(H)NS vaccine; MMRVNS vaccine(Glaxosmithkline)GSK-4406371GSK-4406371A

ClassificationVaccines > Application > Prophylactic vaccine

Mechanisms of ActionImmunostimulants

TargetsNot applicable

Therapy Area/IndicationsRubellaMumpsMeasles +[5]

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited StatesTaiwanPuerto Rico +[5]

CombinationsNo

Global Highest StatusPhase 3 Clinical

Highest Status in ChinaN/A

Originator CompaniesGlaxosmithkline Plc

China Registration ClassN/A

Develop Information

Active CompaniesGlaxosmithkline Plc

Inactive CompaniesN/A

Active IndicationsRubellaMumpsMeasles +[5]

Inactive IndicationsN/A

Other Information

ATC CodeN/A